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Abstract
Background: Higher concentrations of serum lipids and apolipoprotein B100 (apoB) are major
individual risk factors of atherosclerosis and coronary heart disease. Therefore ameliorative effects
of food components against the diseases are being paid attention in the affluent countries. The
present study was undertaken to investigate the effect of taurine on apoB secretion and lipid
metabolism in human liver model HepG2 cells.
Results: The results demonstrated that an addition of taurine to the culture media reduces
triacylglycerol (TG)-mass in the cells and the medium. Similarly, cellular cholesterol-mass was
decreased. Taurine inhibited the incorporation of [14C] oleate into cellular and medium TG,
suggesting the inhibition of TG synthesis. In addition, taurine reduced the synthesis of cellular
cholesterol ester and its secretion, suggesting the inhibition of acyl-coenzyme A:cholesterol
acyltransferase activity. Furthermore, taurine reduced the secretion of apoB, which is a major
protein component of very low-density lipoprotein.
Conclusion: This is a first report to demonstrate that taurine inhibits the secretion of apoB from
HepG2 cells.
Background
Taurine, β-sulphonic amino acid was first isolated more
than 150 years ago from ox bile [1]. Taurine is considered
to be an essential nutrient for human infants and cats and
distributed extensively in mammalian cells and tissues
[1,2]. Its recognized metabolic function in liver is conju-
gation with bile acids, which is important for bile secre-
tion and lipid digestion [3]. Nevertheless, taurine also has
beneficial effects on the liver that include prevention and
treatment of cholestasis and prevention of liver damaged
due to toxic chemicals [4-6].
In past decades, much attention has been paid to the
effects of taurine on bile acid metabolism. Conversely, a
few studies concerning the role of taurine on the other
liver lipids have been reported. Liver is the central organ
of lipid metabolism. Previous in vitro studies with human
hepatoblastoma cells showed that cellular levels of tau-
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rine were associated with the rate of bile acid synthesis,
the reduction of free cellular cholesterol concentration
and the higher expression of low density lipoprotein
(LDL) receptor activity [7]. Similarly, in vivo studies have
shown that supplementation with taurine influences the
serum cholesterol levels in the experimental animals [8].
This was associated with the alterations of activities of 7 α-
hydroxylase and 3-hydroxy-3-methylglutarylutaryl coen-
zyme A reductase in the liver [9].
Thus, it appears that taurine involves not only in biliary
lipid secretion, but also in cholesterol metabolism in the
liver [10]. This possibility is also supported by the previ-
ous reports showing taurine-related changes in liver lipid
composition of the experimental animals [11,12].
However, even though liver is the central organ of lipid
metabolism, only a few studies concerning the effect of
taurine on liver lipid metabolism has been reported. In
addition, the mechanism for these effects has been not
worked out in detail. In addition, there are controversies
about the effect of taurine on serum lipid concentrations
in human beings [1,13].
Taurine biosynthesis derives from the trans-sulphuration
pathway originating with methionine [14]. Liver and
serum taurine levels in rats are reported to be approxi-
mately 3.62 μmol/g liver, and 2.5 μmol/ml serum, respec-
tively [15].
The liver is the organ to synthesize and secrete the lipopro-
teins containing apolipoprotein B100 (apoB). ApoB is an
essential structural component of very low density lipo-
protein (VLDL) and LDL and is required for the intracel-
lular assembly and the secretion of these lipoproteins
[16,17]. The biological role of VLDL is primarily related to
TG transport and eventually to cholesterol transport to the
tissues. The synthesis of all these components occur on
endoplasmic reticulum (ER) membranes and nascent
VLDL particles are assembled from these components
before the lipoprotein formation and secretion is accom-
plished. As the elevation of the concentration of apoB as
well as of LDL cholesterol is regarded as an important risk
factor for coronary artery disease. It is important to inves-
tigate the factors controlling the secretion rate of apoB-
containing lipoprotein by the liver.
The present studies were designed to examine whether
taurine alters apoB secretion and lipid metabolism using
the human hepatoblastoma cells, HepG 2, as a model of
human liver. HepG2 cells have been found to retain many
typical functions of the normal human hepatocytes,
including lipoprotein and apolipoprotein synthesis [17-
19].
Results
Protein content, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide (MTT) cytotoxicactivity and taurine 
concentration in the cells
As shown in Figure 1, the concentration of cellular taurine
was increased in a dose-dependent manner by increasing
concentration of taurine added to the medium. No signif-
icant changes were noted in the cellular protein content
by an addition of 10-5, 10-4, and 10-3 M of taurine under
the present culture medium. Taurine did not affect MTT
activity, suggesting that taurine has no any cytotoxic effect
under the present experimental conditions.
Effect of taurine on triacylglycerol and cholesterol 
contents in the cells and the medium
The contents of TG and cholesterol in the cells and the
medium were measured. When the cells were precultured
in oleate-medium, taurine reduced cellular TG-mass sig-
nificantly, and reduced the secreted TG (Figure 2). Simi-
larly, cellular cholesterol-mass declined by up to 19% by
taurine (Figure 3).
Effect of taurine on lipid syntheses in the cells
Figure 4 shows [14C] oleic acid uptake by TG and choles-
terol ester in the cells and the medium. Taurine inhibited
by up to 50% the incorporation of [14C] oleic acid into
cellular TG. In addition, taurine reduced the synthesis of
HepG2 cells were cultured in the DMEM with or without  taurine for 24 hr (n = 3) Figure 1
HepG2 cells were cultured in the DMEM with or 
without taurine for 24 hr (n = 3). Taurine content was 
measured by using HPLC method.
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cholesterol ester from [14C] oleic acid by 58% in the cells
and reduced its secretion into medium by up to 43%.
Effect of taurine on ApoB secretion to the medium
Figure 5 shows the effect of taurine on apoB concentra-
tions in the medium after 24 h incubation. Taurine at the
concentrations of 10-4 and 10-3 M reduced apoB secretion
by 42% and 45%, respectively.
Discussion
ApoB-containing lipoproteins are assembled in the endo-
plasmic reticulum (ER), with maturation occurring in
Golgi apparatus of hepatocytes prior to secretion [20].
ApoB is required for the assembly and secretion of apoB-
containing lipoproteins which transport hydrophobic lip-
ids, cholesterol ester, and TG in their cores. Regulation of
the assembly and secretion of apoB-containing lipopro-
teins has become an active area of investigation as it is rec-
ognized that overproduction of apoB-containing
lipoproteins may be responsible for coronary artery dis-
ease and hyperlipidemia.
The present study focused on examining the effects of tau-
rine on the secretion of TG, cholesterol and apoB from
HepG2 cells. Taurine had no affect on MTT activity and
cellular protein content in the present cultured condition.
Thus, it suggests that an addition of taurine from the con-
centrations of 10-5 to 10-3 M in the culture medium did
not show any cytotoxic effect. When HepG2 cells contains
a higher concentration of cellular TG by preincubated
with oleic acid-rich medium, taurine remarkably reduced
TG-mass (Figure 2) in both the cells and the medium. In
the same condition, taurine reduced the incorporation of
[14C] oleic acid into cellular TG (Figure 1), suggesting the
inhibition of TG synthesis.
Taurine influenced cholesterol metabolism in HepG2
cells. In condition 1, taurine (10-3  M) significantly
reduced not only the cellular cholesterol-mass (Figure 3)
but also the synthesis and secretion of [14C] oleoylcholes-
terol (Figure 4), suggesting the inhibition of cholesterol
ester synthesis in the cells. It is well known that choles-
terol ester formation is catalyzed by acyl-coenzyme A:
cholesterol acyltransferase (ACAT) form free cholesterol
and acyl-CoA. Reduction of the synthesis of cholesterol
ester may suggest that relatively high amount taurine
exerts for ACAT inhibitor.
ApoB is a major protein component of plasma VLDL and
LDL. First, the effects of the concentration in the medium
on apoB accumulation at the end of the incubation period
were determined. We found that taurine inhibits apoB
secretion from human hepatocytes preincubated with
oleate medium (Figure 5). To determine if changes in
intracellular lipid metabolism were responsible for the
alteration on apoB secretion, appropriate radiolabeled
tracer was added to the medium, the synthesis of choles-
terol, cholesterol ester and TG was determined. Because
high concentration of apoB has been implicated as risk
factor for the development of atherosclerosis, reduction of
apoB suggests the beneficial effect of taurine. Results sug-
gest that there is an associated decrease in apoB secretion
with a decrease in TG synthesis. Thus, a reduction of TG
synthesis may inhibit VLDL-apoB secretion. An important
factor determining VLDL-apoB secretion is the size of the
intracellular TG pool [20]. Availability of TG for lipopro-
tein assembly greatly influences the size of VLDL particle
secreted by the liver.
Effect of taurine on TAG-mass in the cells and in the medium Figure 2
Effect of taurine on TAG-mass in the cells and in the 
medium. HepG2 cells were cultured in the DMEM with (10-
4 or 10-3 M) or without taurine for 24 hr. Values are 
expressed as mean ± SE (n = 4). a, b Different letters show 
significant differences at P < 0.05.
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Effect of taurine on cholesterol-mass in the cells and in the  medium Figure 3
Effect of taurine on cholesterol-mass in the cells and 
in the medium. HepG2 cells were cultured in the DMEM 
with (10-4 or 10-3 M) or without taurine for 24 hr. Values are 
expressed as mean ± SE (n = 4). a, b Different letters show 
significant differences at P < 0.05.
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There is evidence to suggest the cholesterol ester can also
regulate apoB secretion. Our group [19] and Dashti [21]
reported that cholesterol ester synthesis might be a critical
element for regulating apoB secretion by hepatocytes. Ele-
vation of the serum cholesterol concentration is known to
increase the risk of coronary heart disease. Depressed cho-
lesterol ester formation by taurine may be beneficial for
the prevention of such diseases. Recently microsomal tri-
acylglycerol transfer protein (MTP) has been identified as
a necessary factor for the assembly of TG-rich lipoproteins
[22,23]. MTP is localized in the lumen of the endoplasmic
reticulum in the liver and intestine, where it transfers TG,
cholesterol ester, and phospholipids between phospholi-
pid membranes [22,23]. However, effect of taurine on
MTP activity remains to be determined.
Conclusion
Overall, the present study demonstrated that taurine
inhibits the secretion of cholesterol ester, TG and apoB in
HepG2 cells. The reduction of lipid secretion is partly
associated with the inhibition of cellular lipid synthesis.
This is the first direct demonstration that taurine inhibits
the secretion of apoB in HepG2 cells.
Effect of taurine on the incorporation of [14C] oleic acid into cellular TAG and cholesterol-ester and their secretion Figure 4
Effect of taurine on the incorporation of [14C] oleic acid into cellular TAG and cholesterol-ester and their 
secretion. HepG2 cells were cultured in the DMEM with (10-4 or 10-3 M) or without taurine for 24 hr. Values are expressed 
as mean ± SE (n = 4). a, b Different letters show significant differences at P < 0.05.
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Methods
HepG2 cells culture
HepG2 cells were grown in DMEM supplemented with
10% FCS, penicillin (100 μg/ml), and streptomycin (100
μg/ml) at 37°C in an atmosphere containing 95% air and
5% CO2 [19,20]. The medium was renewed at intervals of
2–3 days. For experiments, a dish 3.5 cm in diameter and
a 24-well plate were used and cells were plated out at a
density of 100 × 104 cells/dish or 20 × 104 cells/well.
Before the experiment were performed, cells were preincu-
bated in 1% BSA-DMEM containing 1 mM oleic acid
(oleate-medium) for 24 h, then cultured in 1% BSA-
DMEM with or without (control) taurine (final concentra-
tion: 10-5, 10-4, and 10-3 M) for 24 h (n = 3–4). MTT cyto-
toxicity [24] and protein concentration were determined.
Determination of taurine concentrations in the cells
100 μl of cells and 400 μl of HClO4 (0.2 M) were placed
into a microtube. After cautious shaking, the mixture was
centrifuged (10000 rpm, 3 min, 4°C), then 100 μl of the
supernatant was added to 350 μl of methanol and centri-
fuged again (10000 rpm, furan: methanol: sodium acetate
= 2: 38: 360 (by volume). Taurine concentration was
determined by HPLC according to the procedure.
Determination of lipid content and cellular protein
The cellular protein concentration was determined using
Lowry's method [25]. Total lipids in the cells and the
medium were extracted and purified using the method of
Bligh and Dyer [26]. The contents of TG and cholesterol
were determined enzymatically using commercial kits
(Wako Pure Chemical Industries, Co., Ltd., Osaka).
Determination of lipids synthesis and their secretion
To assess the effects of the addition of taurine on the syn-
thesis and secretion of TG and cholesterol ester in HepG2
cells of experiment 1, 0.5 μCi of [14C] oleic acid was added
to each well. The incorporation of radioactivity into lipids
and their secretion were measured after 24 h incubation.
Total lipid was extracted as described above. Neutral lipid
subclasses were separated by thin-layer chromatography
precoated silica gel G with the solution mixtures petro-
leum ether: diethylether: acetic acid (80:20:1, by vol.)
[27]. The radioactivity was measured with an imaging
plate and BAS 2000 (Fuji Photo Film Co. Ltd. Kanagawa).
The radioactivity was also measured by liquid scintillation
counter (Wallic system 1410, Pharmacia, Uppsala, Swe-
den). Correction was made for background radioactivity
and for quenching by the silica gel.
Determination of apoB secretion into the medium of 
HepG2 cells
ApoB was measured by a sandwich enzyme-linked immu-
nosorbent assay [28].
Statistical analysis
Statistical analysis of data was performed by one-way
ANOVA following by Fisher's PLSD test to establish differ-
ences among the groups. Differences were considered sig-
nificant at P < 0.05.
List of abbreviations
ACAT: acyl-coenzyme A cholesterol acyltransferase; ApoB:
apolipoprotein B100; ER: endoplasmic reticulum; LDL:
low-density lipoprotein; MTP: microsomal triacylglycerol
transfer protein; MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide; TG: triacylglycerol; VLDL:
very low-density lipoprotein.
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